Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Barbara Bober

4PUBLICATIONS

9CO-AUTHORS

Solid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Mar 17, 2025

Possible changes in glucose metabolism induced by radioligand therapy in patients with neuroendocrine neoplasms.

Marek Saracyn, Adam Daniel Durma, Barbara Bober

|Apr 28, 2023

Renal Disturbances during and after Radioligand Therapy of Neuroendocrine Tumors-Extended Analysis of Potential Acute and Chronic Complications.

Marek Saracyn, Adam Daniel Durma, Barbara Bober

|Jan 08, 2023

Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms.

Marek Saracyn, Adam Daniel Durma, Barbara Bober

|Feb 25, 2022

Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms-A Preliminary Study.

Barbara Bober, Marek Saracyn, Kornelia Zaręba

Pageof 1

Frequent Collaborators

4 joint publications

Arkadiusz Lubas

3 joint publications

Adam Daniel Durma

2 joint publications

Grzegorz Kamiński

2 joint publications

Maciej Kołodziej

1 joint publications

Kornelia Zaręba

1 joint publications

Marek Saracyn

1 joint publications

Gabriela Różańska-Grzelak

1 joint publications

Katarzyna Janiak

1 joint publications

Dorota Brodowska-Kania

Frequent Collaborators

4 joint publications

Arkadiusz Lubas

3 joint publications

Adam Daniel Durma

2 joint publications

Grzegorz Kamiński

2 joint publications

Maciej Kołodziej

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

A Practical Guide for the Production and PET/CT Imaging of <sup>68</sup>Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of <sup>68</sup>Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on : Apr 17, 2019

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

A Practical Guide for the Production and PET/CT Imaging of <sup>68</sup>Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of <sup>68</sup>Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on : Apr 17, 2019

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

See more related videos